Tanaka, Y. Et Al. 2023. Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.26, no.7 , 1248-1259.

Tanaka, Y., Takeuchi, T., Haaland, D., Hall, S., Inanc, N., Li, Z., ... Xavier, R. M. M.(2023). Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.26, no.7, 1248-1259.

Tanaka, Yoshiya Et Al. "Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials," INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.26, no.7, 1248-1259, 2023

Tanaka, Yoshiya Et Al. "Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials." INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.26, no.7, pp.1248-1259, 2023

Tanaka, Y. Et Al. (2023) . "Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials." INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.26, no.7, pp.1248-1259.

@article{article, author={Yoshiya Tanaka Et Al. }, title={Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials}, journal={INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES}, year=2023, pages={1248-1259} }